Effect of transcutaneous electrical acupoint stimulation on hiccup during painless gastroscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300073916

Enrollment

Unknown

Registered

2023-07-25

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hiccup

Interventions

Transcutaneous electrical acupoint stimulation group:Transcutaneous electrical acupoint stimulation was administered

Control group:Only the electrodes were attached to the acupoints to connect the pulse electrotherapy instrument, but no stimulation was given.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ? patients who planned to undergo gastroscopy under sedation; ? Age of 18-65 years old; ? Body mass index (BMI) 18.5-30 kg/m2; ? voluntary participation in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) history of severe heart, brain, lung, liver, kidney or metabolic diseases; (2) patients with neuromuscular disease or mental disease, abuse of narcotic analgesics or sedatives; ? receiving acupuncture and sedative, analgesic or antiemetic drugs 24 hours before gastroscopy; ? Skin defect, infection and lesion near the stimulation point; 5) inability to cooperate or communicate with the research team.

Design outcomes

Primary

Measure	Time frame
Incidence of hiccups;	—

Secondary

Measure	Time frame
Time to loss of consciousness;awakening time;Time to leave the recovery area;Dose of remimazolam;	—

Countries

China

Contacts

Public ContactLiang Sheng Miao

Weinan Central Hospital

401167718@qq.com+86 139 9168 8991

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026